Tumor Ablation Market Size, Share & Trends Report

Tumor Ablation Market Size, Share & Trends Analysis Report By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application, And Segment Forecasts, 2012 - 2022

  • Published Date: Apr, 2018
  • Base Year for Estimate: 2014
  • Report ID: 978-1-68038-746-9
  • Format: Electronic (PDF)
  • Historical Data: 2012 - 2013
  • Number of Pages: 92

Industry Insights

The global tumor ablation market size was valued at USD 756.0 million in 2015 and is expected to grow at CAGR of 11.1% over the forecast period. Increasing prevalence of cancer is the major factor contributing for the growth of the market. Based on the statistics published by World Health Organization (WHO), about 13% of the people suffer from cancer worldwide. In addition, there is 70.0% rise in cancer cases expected over the next few decades. Therefore, more than 100 cancer types require tumor ablation thereby boosting market growth over the forecast period.

Technological advancements in the field of thermal ablation technologies is anticipated to fuel market growth. The rapid rise in aging population is expected to double. According to the statistics provided by WHO, an increase in global population from 12.0%-22.0% is expected from 2015 to 2050.

North America tumor ablation market

With the increasing geriatric population, the demand for minimally invasive surgeries (MIS) is rising. Through minimally invasive surgeries, the patients experience lesser trauma and result in faster recovery in comparison to invasive procedures. Therefore, the demand for minimally invasive procedures such as radiofrequency ablation is increasing and thereby leading to growth in the market.

Extensive usage of minimally invasive procedures owing to their benefits such as speedy recovery, less trauma and minimal complications is anticipated to boost the demand for tumor ablation technologies. Active role of healthcare agencies and government to create awareness about various cancer types is expected to accentuate the usage of tumor ablation therapy.

Besides the use of thermal ablation, techniques such as laser ablation, irreversible electroporation, High Intensity Focused Ultrasound (HIFU) are also clinically growing, concurrently propelling the tumor ablation industry.

Increasing per capita income is driving market growth positively. The per capita income in developed as well as developing nations is encouraging people to undergo advanced therapy for tumors, thus assisting market growth.

Technology Insights

On the basis of technology, the market has been segmented into microwave, radiofrequency, cryoablation and other technologies such as radio iodine, HIFU, laser ablation. Radiofrequency tumor ablation technology held substantial share in 2015. Radiofrequency ablation makes use of imaging devices and needle electrode probe to pierce through skin.

High frequency currents are passed through electrode for generating heat in order to destroy tumor cells. These electric currents generate sound waves; these waves then generate heat reacting target cell molecule. Prominent application of this technology in solid tumor removal all over the body and its specificity contributed its growth. Rising usage of this technology in solid tumor excision is prime factor responsible for its lucrative growth. Moreover, efficiency and specificity of this method contributed to its growth.

Whereas, microwave ablation technology is anticipated to witness remunerative growth over the forecast period owing to benefits offered by this technology. Microwave ablation is utilization of electromagnetic methods for tumor destruction with the device having frequencies of at least 900 MHz Microwave ablation is advantageous over other techniques, in terms of effectiveness treating tumor.

The benefits of this technology include larger tumor ablation volume, consistency in high temperature, lesser ablation time, reduced procedural pain, and optimal heating of the cystic mass. These benefits are assisting microwave tumor ablation technology to grow. Minimum procedure time (5-10 minutes), improved efficacy with minimal complications and reduced hospital stay are expected to drive growth of this segment.

Treatment Insights

On the basis of treatment, the market has been segmented into surgical procedures, laparoscopic procedures and percutaneous procedures. Surgical ablation segment held substantial share of 42.1% in 2015. Increased prevalence of cancers such liver cancer and breast cancer, which require open surgical procedures, contributed to growth of surgical procedures. However, percutaneous procedures are expected to exhibit lucrative growth over the forecast period. Rising demand for minimally invasive surgeries is high-impact rendering factor contributing to their growth. These procedures offer faster recovery, decreased scarring, and increased safety. However, higher complications associated with it, post-surgical discomfort, and slower recovery restrain the usage. 

On the other hand, Percutaneous ablation has been anticipated to be the fastest growing segment. This procedure involves treating tumors through skin; this is an advanced way to treat the tumors. A small incision is made on skin through which radiofrequency probe is inserted, which terminates the tumor in target tissues. Quick surgery time, faster recovery, and patient comfort are high-impact rendering factors for growth of this segment.

Application Insights

On the basis of application, the market is segmented into liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers such as kidney cancer, bone metastasis, and ENT cancer. Other segment includes various types of cancers such as bone metastasis, kidney cancer, and ENT cancer. Availability of advanced methods and increasing prevalence of these cancers are anticipated to assist growth of industry. Liver cancer accounted for largest shares in 2015. Liver cancer is most prominent in males rather than females, and rising incidence of bile duct cancer as well as primary liver cancer resulted in their dominion.

Lung cancer has been anticipated to grow with the highest CAGR during the forecast period. The prevalence of lung cancer is rising, especially cancer types such as Non-Small Cell Lung Cancer (NSCLC). The NSCLC utilizes radiofrequency ablation prominently, use of needle or probe till it reaches target cells, and destruction of tumor cells by generating heat is the basic methodology involved. Local anesthesia is given sometimes when it is expected that patient would undergo trauma.

Regional Insights 

North America dominated the overall tumor ablation market with over 32.0% share in 2015. Major factors contributing to growth of this region include government support for quality healthcare, high purchasing power parity, availability of reimbursement, and increasing prevalence of cancers in the U.S. and Canada. For instance, in the U.S., the Patient Protection and Affordable Care Act (PPACA), also known as ObamaCare, promotes quality and affordability of health insurance and reduces the cost of healthcare for individual and government. In addition, precision medicine initiative is formulating the tailored strategies on unique characteristics of diseases. Hence, such government initiatives are helping to improve the overall healthcare system, thus boosting growth of tumor ablation market.

Global tumor ablation market

Europe accounted for 24.3% share in the global tumor ablation market. Greater extent of public funding in Europe’s healthcare system has contributed to this growth. Moreover, growing geriatric population base coupled with government support to control cancer led to substantial growth of this region. For instance, formation of bodies, such as the European Cancer Observatory, created awareness about cancer.

Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving healthcare infrastructure with government initiatives. Moreover, economic developments in countries such as India and China are expected to help market growth. Huge population base with low per capita income in Asia Pacific led to high demand for affordable treatment options. Multinational companies are looking forward to investing in developing countries such as India and China. Thus, many collaborative partnerships and strategic alliances are taking place with companies in this region.

Tumor Ablation Market Share Insights

Key players of this market are Galil Medical Inc., Misonix Inc., HealthTronics, Angiodynamics, (Covidien), Boston Scientific Corporation, Medtronic Plc. SonaCare Medical, EDAP TMS S.A. and Neuwave Medical Inc. These industry players have adopted various strategies to sustain their position in the market. For instance, New product launches, collaborations, technological advancements, mergers and acquisitions are the most popular initiatives in this industry.

For instance, Covidien Plc acquired BARRX Medical Inc. leading to rights of Medtronic on the product Barrx Flex RFA System and other bipolar RF ablation devices. The acquisition led to generation of goodwill for the company, hence making the excessive price for the takeover fair.

Similarly, Galil Medical Inc. launched a new family of cryoablation needles, IcePearl 2.1 CX, IceFORCE 2.1CX. Launch of these products is expected to strengthen the company’s product portfolio.

Report Scope



Base year for estimation


Actual estimates/Historical data

2012 - 2013

Forecast period

2015 - 2022

Market representation

Revenue in USD Million & CAGR from 2017 to 2022

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, UK, Germany, France, Japan, China, Brazil, Mexico, and South Africa

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2012 to 2022. For the purpose of this study, Grand View Research, Inc. has segmented the global tumor ablation market report on the basis of technology, treatment, application, and region:

  • Technology Outlook (Revenue, USD Million, 2012 - 2022)

    • Radiofrequency ablation

    • Microwave ablation

    • Cryoablation

    • Other ablation technologies

  • Treatment Outlook (Revenue, USD Million, 2012 - 2022)

    • Surgical ablation

    • Laparoscopic ablation

    • Percutaneous ablation

  • Application Outlook (Revenue, USD Million, 2012 - 2022)

    • Liver cancer

    • Breast cancer

    • Lung cancer

    • Prostate cancer

    • Other cancer

  • Regional Outlook (Revenue, USD Million, 2012 - 2022)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,450
Multi User (2-5) - $6,450
BI Library Access - $8,450

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified